Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>GQG Partners (GQG) raised US$868m in its Australia IPO in Oct 2021. Its IPO linked lockup is set to expire soon.</li>
<li>GQG is a global investment boutique with a focus on managing active equity portfolios.</li>
<li>In this note, we will talk about the lock-up dynamics and updates since our last note.</li>
</ul>


GQG Partners (GQG) raised US$868m in its Australia IPO in Oct 2021. Its IPO linked lockup is set to expire soon.
GQG is a global investment boutique with a focus on managing active equity portfolios.
In this note, we will talk about the lock-up dynamics and updates since our last note.


GQG Partners IPO Lock-Up - Tightly Held by Founders, PAC Could Exit

Australia & New Zealand Bankin / Equity Capital Markets

<ul>
<li>ANZ aims to raise around US$2.4bn (A$3.5bn) via a renounceable entitlement offer to part fund the purchase of Suncorp Bank.</li>
<li>In our view, neither the fundraising nor the acquisition appear to be particularly well flagged. ANZ’s withdrawal from MYOB talks might be the most positive thing about the announcement.</li>
<li>In this note, we will talk about the deal dynamics and run the deal through our ECM framework.</li>
</ul>


ANZ aims to raise around US$2.4bn (A$3.5bn) via a renounceable entitlement offer to part fund the purchase of Suncorp Bank.
In our view, neither the fundraising nor the acquisition appear to be particularly well flagged. ANZ’s withdrawal from MYOB talks might be the most positive thing about the announcement.
In this note, we will talk about the deal dynamics and run the deal through our ECM framework.


ANZ Renounceable Entitlement Offer - Dilute Now, Accrete Later. Still Appears Better than MYOB

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>Fresh from successfully taking out <strong><a href="https://www.smartkarma.com/entities/sydney-airport" target="_blank" data-smartkarma-citation="entities:19063:1" rel="noopener">Sydney Airport (SYD AU)</a></strong> earlier this year, IFM is reportedly on the cusp of submitting a non-binding indicative proposal for <strong><a href="https://www.smartkarma.com/entities/atlas-arteria-ltd" target="_blank" data-smartkarma-citation="entities:14430:1" rel="noopener">Atlas Arteria (ALX AU)</a></strong> </li>
<li>A proposal is contingent on being granted limited due diligence. Meanwhile, IFM has accumulated an economic interest in ALX of 15%. </li>
<li>ALX said they have not received any information on a proposal. Expect that to occur shortly. </li>
</ul>


Fresh from successfully taking out Sydney Airport (SYD AU) earlier this year, IFM is reportedly on the cusp of submitting a non-binding indicative proposal for Atlas Arteria (ALX AU) 
A proposal is contingent on being granted limited due diligence. Meanwhile, IFM has accumulated an economic interest in ALX of 15%. 
ALX said they have not received any information on a proposal. Expect that to occur shortly. 


Atlas Arteria (ALX AU): IFM Investors Comes Knocking

Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Periscope Analytics

Periscope Analytics focuses on event-driven trades across Asia Pacific and provides comprehensive, timely and systematic coverage of index changes to major Asia Pacific indices in a structured manner.

The analysis includes forecasted inclusions and exclusions to all major Asian indices that have significant amount of tracking assets, including estimates of passive buy/sell flow on the stocks. The service also provides commentary and impact of market consultations, ground rule changes, and other events (IPOs, spin-offs, M&A) that could lead to index changes and passive flow.

Periscope Analytics works with multi-strategy hedge funds, proprietary trading firms, stat arb trading groups and long-only investors that invest and trade in the Asia Pacific region with the data being used to trade index rebalances, avoid pre-positioning and passive flow, and to time entry into and exit from stocks.

Event-Driven Trades Across Asia Pacific

<ul>
<li>IFM bought around 67.1m shares (7% of shares out) of <a href="https://www.smartkarma.com/entities/atlas-arteria-ltd" target="_blank" data-smartkarma-citation="entities:14430:1" rel="noopener">Atlas Arteria (ALX AU)</a> at A$8.1/share last evening taking its total holding to around 15% of shares outstanding.</li>
<li>IFM intends to request certain information that would help it assess whether it can submit a non-binding proposal to acquire all the shares in <a href="https://www.smartkarma.com/entities/atlas-arteria-ltd" target="_blank" data-smartkarma-citation="entities:14430:1" rel="noopener">Atlas Arteria</a> that it does not own.</li>
<li>With the indicative offer floor set at A$8.1/share, <a href="https://www.smartkarma.com/entities/atlas-arteria-ltd" target="_blank" data-smartkarma-citation="entities:14430:1" rel="noopener">Atlas Arteria</a> still trades cheaper than <a href="https://www.smartkarma.com/entities/transurban-group" target="_blank" data-smartkarma-citation="entities:593:1" rel="noopener">Transurban Group</a> and offers a 14% premium to last close and even higher premiums to longer-term VWAPs.</li>
</ul>


IFM bought around 67.1m shares (7% of shares out) of Atlas Arteria (ALX AU) at A$8.1/share last evening taking its total holding to around 15% of shares outstanding.
IFM intends to request certain information that would help it assess whether it can submit a non-binding proposal to acquire all the shares in Atlas Arteria that it does not own.
With the indicative offer floor set at A$8.1/share, Atlas Arteria still trades cheaper than Transurban Group and offers a 14% premium to last close and even higher premiums to longer-term VWAPs.


Atlas Arteria Group (ALX AU): IFM Makes an Approach

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<ul>
<li>IFM Investors is seeking to amass a 15% interest in <a href="https://www.smartkarma.com/entities/atlas-arteria-ltd" target="_blank" data-smartkarma-citation="entities:14430:1" rel="noopener">Atlas Arteria (ALX AU)</a> through a combination of total return swaps and physical shares, <a href="https://www.afr.com/street-talk/atlas-arteria-in-departures-lounge-as-ifm-investors-makes-big-move-20220607-p5arso" target="_blank" rel="noopener">according to AFR</a>.</li>
<li>If successful in securing its stake, IFM intends to request due diligence access to judge if it can lob a privatisation proposal. </li>
<li>Jarden, IFM’s broker, was buying shares at A$8.10 a share, a 14% premium to the last close but below the Australian takeover premium range of 20% to 40%.</li>
</ul>


IFM Investors is seeking to amass a 15% interest in Atlas Arteria (ALX AU) through a combination of total return swaps and physical shares, according to AFR.
If successful in securing its stake, IFM intends to request due diligence access to judge if it can lob a privatisation proposal. 
Jarden, IFM’s broker, was buying shares at A$8.10 a share, a 14% premium to the last close but below the Australian takeover premium range of 20% to 40%.


Atlas Arteria in the Crosshairs of IFM Investors

Australia

Transurban Group owns and operates urban toll road networks. The Company has core capabilities in network planning and forecasting, operations and customer management, project development and delivery, technology application, and community engagement. Transurban operates in Australia and North America.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Transurban Group (TCL AU)

GQG Partners IPO Lock-Up - Tightly Held by Founders, PAC Could Exit

GQG Partners (GQG) raised US$868m in its Australia IPO in Oct 2021. Its IPO linked lockup is set to expire soon, soon after it reports its results.

Sumeet Singh

ANZ Renounceable Entitlement Offer - Dilute Now, Accrete Later. Still Appears Better than MYOB

ANZ aims to raise around US$2.4bn (A$3.5bn) via a renounceable entitlement offer to part fund the purchase of Suncorp Bank.

Sumeet Singh

Atlas Arteria (ALX AU): IFM Investors Comes Knocking

Atlas Arteria Limited (ASX:ALX) is trading 2% through terms. I'd be buying here and on any pull back. I see A$8.10 is just the opening salvo for IFM.

David Blennerhassett

Atlas Arteria Group (ALX AU): IFM Makes an Approach

IFM has bought 7% of Atlas Arteria at A$8.1/share and now holds 15% of the company. An indicative offer should be made soon and there is a decent...

Brian Freitas

Atlas Arteria in the Crosshairs of IFM Investors

IFM Investors is seeking to amass a 15% interest in Atlas which could lead to a privatisation proposal. IFM's buying at A$8.10 sets a floor price...

Arun George

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)